Frontiers in Neuroscience (May 2024)

Advancements and challenges in amyotrophic lateral sclerosis

  • David Bradford,
  • Kathleen E. Rodgers

DOI
https://doi.org/10.3389/fnins.2024.1401706
Journal volume & issue
Vol. 18

Abstract

Read online

Amyotrophic lateral sclerosis (ALS) continues to pose a significant challenge due to the disease complexity and heterogeneous manifestations. Despite recent drug approvals, there remains a critical need for the development of more effective therapies. This review explores the underlying mechanisms involved; including neuroinflammation, glutamate mediated excitotoxicity, mitochondrial dysfunction, and hypermetabolism, and how researchers are trying to develop novel drugs to target these pathways. While progress has been made, the unmet need of ALS patients highlights the urgency for continued research and resource allocation in the pursuit of effective treatments.

Keywords